Privia Health Group, Inc. - Common Stock (PRVA)
24.42
+0.48 (2.01%)
NASDAQ · Last Trade: Nov 6th, 5:10 PM EST
Detailed Quote
| Previous Close | 23.94 |
|---|---|
| Open | 23.94 |
| Bid | 21.00 |
| Ask | 25.00 |
| Day's Range | 23.66 - 24.45 |
| 52 Week Range | 18.92 - 28.82 |
| Volume | 2,807,726 |
| Market Cap | 2.58B |
| PE Ratio (TTM) | 93.92 |
| EPS (TTM) | 0.3 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,316,482 |
Chart
About Privia Health Group, Inc. - Common Stock (PRVA)
Privia Health Group Inc is a leading healthcare technology company that offers a platform designed to enhance the way healthcare providers deliver care to patients. The company focuses on empowering independent healthcare providers by providing them with the tools and resources necessary to optimize their practices and improve patient outcomes. Through its integrated technology solutions, Privia facilitates seamless communication, care coordination, and data management, enabling providers to deliver high-quality care while maintaining efficiency and sustainability within their practices. The company aims to transform the healthcare landscape by promoting value-based care and fostering strong patient-provider relationships. Read More
News & Press Releases
Privia Health Group (NASDAQ:PRVA) raised its 2026 financial outlook after reporting growth in providers, patient attribution and adjusted earnings through the first nine months of the year. The company also announced a $36 million acquisition that will expand its Medicare value-based care footprint
Via MarketBeat · November 6, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 13.2% year on ye...
Via StockStory · November 6, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via StockStory · November 5, 2026
Privia lifts 2026 outlook as it exits Montana and adds American Choice.
Via The Motley Fool · November 5, 2026
Privia Health Group (NASDAQ:PRVA) Jumps on Q2 Revenue Beatchartmill.com
Via Chartmill · August 6, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q3 2026, with revenue up 13.2% year on year to $657 milli...
Via StockStory · November 5, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting earnings this Thursday before market hours. Here’s what to look for. Privia Healt...
Via StockStory · November 3, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Via StockStory · October 27, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · October 19, 2026
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...
Via StockStory · September 30, 2026
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via StockStory · September 16, 2026
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...
Via StockStory · September 14, 2026
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ...
Via StockStory · September 9, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Via StockStory · September 3, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · August 28, 2026
Privia Health has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $21.63. The stock also fell short of th...
Via StockStory · August 20, 2026
Net income surged 237% while attributed lives grew 19%, signaling strong operational momentum.
Via The Motley Fool · August 13, 2026
Privia Health’s second quarter results were met with a negative market reaction as investors digested the company’s strong revenue growth alongside a materia...
Via StockStory · August 13, 2026
Privia Health Group (NASDAQ:PRVA) reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following wh
Via MarketBeat · August 7, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 mi...
Via StockStory · August 7, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 21.4% year on y...
Via StockStory · August 6, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting earnings this Thursday morning. Here’s what investors should know. Privia Health ...
Via StockStory · August 4, 2026
Since January 2026, Privia Health has been in a holding pattern, posting a small return of 3.6% while floating around $24.97. Is there a buying opportunity i...
Via StockStory · July 24, 2026
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Via StockStory · July 16, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · July 15, 2026
